Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Angela Dispenzieri Rafael Fonseca |
| Publication date | June 10, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |